Oxaliplatin-based therapeutics is a widely used treatment approach for hepatocellular carcinoma (HCC) patients
however, drug resistance poses a significant clinical challenge. Epigenetic modifications have been implicated in the development of drug resistance. In our study, employing siRNA library screening, we identified that silencing the m